St Jude Medical Inc (STJ)

80.82
0.13 0.16
NYSE : Health Care
Prev Close 80.69
Open 80.80
Day Low/High 80.72 / 81.31
52 Wk Low/High 48.83 / 84.00
Volume 14.74M
Avg Volume 2.67M
Exchange NYSE
Shares Outstanding 285.72M
Market Cap 23.09B
EPS 3.10
P/E Ratio 35.39
Div & Yield 1.24 (1.50%)
St. Jude Medical (STJ) Stock Price Target Lowered at Canaccord

St. Jude Medical (STJ) Stock Price Target Lowered at Canaccord

St. Jude Medical's (STJ) price target was cut to $59 from $64 at Canaccord on Thursday.

Why St. Jude Medical (STJ) Stock Is Down Today

Why St. Jude Medical (STJ) Stock Is Down Today

St. Jude Medical (STJ) shares are lower after the company provided a light guidance for the fourth quarter and lowered its full year 2015 guidance.

St. Jude Medical Reports Third Quarter 2015 Results

St. Jude Medical Reports Third Quarter 2015 Results

St. Jude Medical, Inc.

Fly Watch: Is HeartWare A Takeover Candidate After Selloff?

Fly Watch: Is HeartWare A Takeover Candidate After Selloff?

Shares of HeartWare dropped yesterday after the announcement that it was probing "reported adverse events" experienced by certain patients who participated in a clinical trial of it's MVAD heart pump.

St Jude Medical Becomes #181 Most Shorted S&P 500 Component, Replacing Duke Energy

St Jude Medical Becomes #181 Most Shorted S&P 500 Component, Replacing Duke Energy

The most recent short interest data has been released by the NASDAQ for the 09/30/2015 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying components of the S&P 500 by "days to cover." There are a number of ways to look at short data, for example the total number of shares short; but one metric that we find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares typically traded. The number of shares short is then compared to the average daily volume, in order to calculate the total number of trading days it would take to close out all of the open short positions if every share traded represented a short position being closed.

Barbarian At The Gate: St Jude Medical (STJ)

Barbarian At The Gate: St Jude Medical (STJ)

Trade-Ideas LLC identified St Jude Medical (STJ) as a "barbarian at the gate" (strong stocks crossing above resistance with today's range greater than 200%) candidate

Courtesy Of St. Jude Medical (Photo: Business Wire)

Courtesy Of St. Jude Medical (Photo: Business Wire)

St. Jude Medical, Inc.

St. Jude Medical Completes Acquisition Of Thoratec

St. Jude Medical Completes Acquisition Of Thoratec

St. Jude Medical, Inc.

Engaged Capital Pressures HeartWare to Drop Valtech Deal

Engaged Capital Pressures HeartWare to Drop Valtech Deal

The activist investor is calling for the end of the proposed $860 million deal, vowing to campaign against it and seek board seats if its advice goes unheeded.

St. Jude Medical Announces Third Quarter 2015 Earnings Conference Call

St. Jude Medical Announces Third Quarter 2015 Earnings Conference Call

St. Jude Medical, Inc.

St. Jude Medical And Mended Little Hearts Unveil The Mended Little HeartGuide, A Comprehensive Guidebook For Families Of Kids With Congenital Heart Defects

St. Jude Medical And Mended Little Hearts Unveil The Mended Little HeartGuide, A Comprehensive Guidebook For Families Of Kids With Congenital Heart Defects

Over 1 million babies worldwide are born each year with congenital heart defects (CHD) - the most common birth defect and the most common cause of infant death from birth defects.

Cramer: Medtronic to Go Higher, Joy Global to Go Lower

Cramer: Medtronic to Go Higher, Joy Global to Go Lower

Medtronic reported good earnings results and the stock can move higher as a result. Conversely, Joy Global seems destined to go lower due to crumbling sales, Cramer says.

HeartWare Falters After Announcing Valtech Cardio Acquisition

HeartWare Falters After Announcing Valtech Cardio Acquisition

The cardiac device company's shares dipped more than 20% on news of the transaction, which could be worth up to $860 million.

Jim Cramer -- Watch Campbell Soup, Medtronic Earnings

Jim Cramer -- Watch Campbell Soup, Medtronic Earnings

Campbell Soup and Medtronic both report their latest quarterly results on Thursday, and Jim Cramer is watching them closely.

Cramer's Takes on Celgene, Qorvo, Boston Scientific and Many More

Cramer's Takes on Celgene, Qorvo, Boston Scientific and Many More

Cramer gives his opinion on a slew of stocks as he answers viewers' Twitter questions.

Jim Cramer Says Buy Celgene at $113 or Below, Skyworks in the $70s

Jim Cramer Says Buy Celgene at $113 or Below, Skyworks in the $70s

Jim Cramer answered viewers' Twitter from the floor of the New York Stock Exchange, commenting on Qorvo (QRVO), Celgene (CELG), and Boston Scientific (BSX).

St Jude Medical Takes Over #112 Spot From EQT

St Jude Medical Takes Over #112 Spot From EQT

In a study of analyst recommendations at the major brokerages, for the underlying components of the S&P 500, St Jude Medical Inc has taken over the #112 spot from EQT Corp. , according to ETF Channel.

Stocks Trimming Gains as Rally Fades

Stocks Trimming Gains as Rally Fades

Stocks pare gains by Thursday afternoon, even as crude oil closes above $42 a barrel and the energy sector soars.

Cramer Remains Cautious on Stocks

Cramer Remains Cautious on Stocks

He recommends that retail investors take a wait-and-see approach.

Jim Cramer Says Retail Investors Should Wait to Buy Stocks

Jim Cramer Says Retail Investors Should Wait to Buy Stocks

Stocks climbed early Thursday, but Jim Cramer, portfolio manager of Action Alerts PLUS, remains cautious still.